BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25410605)

  • 1. A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer.
    Keane MG; Horsfall L; Rait G; Pereira SP
    BMJ Open; 2014 Nov; 4(11):e005720. PubMed ID: 25410605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants.
    Power R; Leavy C; Nolan C; White N; Clarke R; Cadoo KA; Gallagher DJ; Lowery MA
    Fam Cancer; 2021 Apr; 20(2):97-101. PubMed ID: 32918181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sociodemographic trends in the incidence of pancreatic and biliary tract cancer in UK primary care.
    Keane MG; Horsfall LJ; Rait G; Pereira SP
    PLoS One; 2014; 9(9):e108498. PubMed ID: 25268478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying symptoms associated with diagnosis of pancreatic exocrine and neuroendocrine neoplasms: a nested case-control study of the UK primary care population.
    Liao W; Clift AK; Patone M; Coupland C; González-Izquierdo A; Pereira SP; Hippisley-Cox J
    Br J Gen Pract; 2021 Nov; 71(712):e836-e845. PubMed ID: 34544691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
    Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
    Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic, clinical, and pathological features of early onset pancreatic cancer patients.
    Ntala C; Debernardi S; Feakins RM; Crnogorac-Jurcevic T
    BMC Gastroenterol; 2018 Sep; 18(1):139. PubMed ID: 30208959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on estimates.
    Minicozzi P; Cassetti T; Vener C; Sant M
    Cancer Epidemiol; 2018 Aug; 55():52-60. PubMed ID: 29777994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
    Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
    LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
    Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
    Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the incidence and management of biliary tract cancer: a French population-based study.
    Lepage C; Cottet V; Chauvenet M; Phelip JM; Bedenne L; Faivre J; Bouvier AM
    J Hepatol; 2011 Feb; 54(2):306-10. PubMed ID: 21056501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls.
    Carlsen AL; Joergensen MT; Knudsen S; de Muckadell OB; Heegaard NH
    Pancreas; 2013 Oct; 42(7):1107-13. PubMed ID: 24048453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.
    Blackford AL; Canto MI; Klein AP; Hruban RH; Goggins M
    J Natl Cancer Inst; 2020 Nov; 112(11):1162-1169. PubMed ID: 31958122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk.
    Gomez-Rubio P; Rosato V; Márquez M; Bosetti C; Molina-Montes E; Rava M; Piñero J; Michalski CW; Farré A; Molero X; Löhr M; Ilzarbe L; Perea J; Greenhalf W; O'Rorke M; Tardón A; Gress T; Barberá VM; Crnogorac-Jurcevic T; Muñoz-Bellvís L; Domínguez-Muñoz E; Gutiérrez-Sacristán A; Balsells J; Costello E; Guillén-Ponce C; Huang J; Iglesias M; Kleeff J; Kong B; Mora J; Murray L; O'Driscoll D; Peláez P; Poves I; Lawlor RT; Carrato A; Hidalgo M; Scarpa A; Sharp L; Furlong LI; Real FX; La Vecchia C; Malats N;
    Ann Oncol; 2017 Jul; 28(7):1618-1624. PubMed ID: 28383714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers.
    Limb C; Liu DSK; Veno MT; Rees E; Krell J; Bagwan IN; Giovannetti E; Pandha H; Strobel O; Rockall TA; Frampton AE
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study.
    Gad MM; Saad AM; Al-Husseini MJ; Abdel-Gawad YM; Alsalhani OM; Alhaddad R; Mohamad B; Saleh MA; Simons-Linares CR
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):204-210. PubMed ID: 31420297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age distribution patterns of patients with conventional ductal adenocarcinoma of the pancreas. A single-institution study of 580 cases re-evaluated using current histopathological diagnostic criteria.
    Liszka Ł; Pająk J; Mrowiec S; Zielińska-Pająk E; Lampe P; Gołka D
    Pol J Pathol; 2010; 61(2):65-77. PubMed ID: 20924989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
    J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced risk of pancreatic cancer associated with asthma and nasal allergies.
    Gomez-Rubio P; Zock JP; Rava M; Marquez M; Sharp L; Hidalgo M; Carrato A; Ilzarbe L; Michalski C; Molero X; Farré A; Perea J; Greenhalf W; O'Rorke M; Tardón A; Gress T; Barberà V; Crnogorac-Jurcevic T; Domínguez-Muñoz E; Muñoz-Bellvís L; Alvarez-Urturi C; Balcells J; Barneo L; Costello E; Guillén-Ponce C; Kleeff J; Kong B; Lawlor R; Löhr M; Mora J; Murray L; O'Driscoll D; Peláez P; Poves I; Scarpa A; Real FX; Malats N;
    Gut; 2017 Feb; 66(2):314-322. PubMed ID: 26628509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.